NSE: BIOCON • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding44.91%
FII Holding7.14%
DII Holding24.16%
Public Holding10.23%
Total Shareholders394,215
As ofJan 2026
View the latest shareholding pattern of Biocon (BIOCON) including promoter, FII, DII, and public holdings.
Track BIOCON ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal.
(See BIOCON dividend growth)
Biocon (BIOCON) Shareholding Summary
Promoters have decreased holding from 54.45% to 44.91% in Jan 2026
FII/FPI have decreased holdings from 7.39% to 7.14% in Jan 2026
DIIs have increased holdings from 21.71% to 24.16% in Jan 2026
Institutional investors have increased holdings from 29.10% to 31.30% in Jan 2026
Public holding has decreased from 12.38% to 10.23% in Jan 2026
Number of shareholders decreased from 394,279 to 394,215 in Jan 2026
BIOCON Quarterly Ownership Changes
Quarter-over-quarter changes for Biocon from Dec 2025 to Jan 2026.
Promoter Holding Change
Dec 2025 to Jan 2026
-9.54%
FII Holding Change
Dec 2025 to Jan 2026
-0.25%
DII Holding Change
Dec 2025 to Jan 2026
+2.45%
Public Holding Change
Dec 2025 to Jan 2026
-2.15%
Biocon (BIOCON) Quarterly Shareholding Trends
Visual breakdown of BIOCON ownership distribution over time. Learn more about BIOCON share price charts.
Promoter
FII
DII
Public
Government
Rising institutional holdings in BIOCON often correlate with improved fundamentals. Check out BIOCON true value.
Biocon (BIOCON) Shareholding Data
Download complete BIOCON ownership data for offline analysis. Discover Biocon market worth.
Period
Promoter (%)
FII (%)
DII (%)
Govt (%)
Public (%)
Other (%)
Total (%)
Shareholders
Jan 2026
44.91%
7.14%
24.16%
0.00%
10.23%
13.55%
99.99%
394,215
Dec 2025
54.45%
7.39%
21.71%
0.00%
12.38%
4.06%
99.99%
394,279
Sept 2025
54.45%
6.61%
22.10%
0.00%
12.71%
4.12%
99.99%
413,191
Jun 2025
54.45%
6.04%
22.82%
0.00%
12.58%
4.10%
99.99%
430,217
Mar 2025
60.64%
5.66%
15.72%
0.00%
13.63%
4.34%
99.99%
424,297
Dec 2024
60.64%
5.66%
15.37%
0.00%
14.07%
4.27%
100.01%
427,705
Sept 2024
60.64%
5.93%
14.44%
0.00%
14.57%
4.42%
100.00%
439,503
Jun 2024
60.64%
5.90%
14.30%
0.00%
14.63%
4.53%
100.00%
443,513
Mar 2024
60.64%
5.63%
13.68%
0.00%
15.53%
4.52%
100.00%
470,261
Dec 2023
60.64%
6.55%
14.51%
0.00%
14.47%
3.83%
100.00%
434,339
Sept 2023
60.64%
7.96%
14.08%
0.00%
13.61%
3.70%
99.99%
415,046
Jun 2023
60.64%
0.00%
12.56%
0.00%
13.34%
13.46%
100.00%
412,441
Mar 2023
60.64%
0.00%
11.90%
0.00%
13.21%
14.26%
100.01%
411,086
Dec 2022
60.64%
0.00%
8.63%
0.00%
12.46%
18.27%
100.00%
369,816
Sept 2022
60.64%
0.00%
7.76%
0.00%
12.07%
19.54%
100.01%
341,016
Jun 2022
60.64%
0.00%
7.30%
0.00%
10.72%
21.35%
100.01%
347,911
Mar 2022
60.64%
0.00%
7.79%
0.00%
10.87%
20.70%
100.00%
364,502
Dec 2021
60.64%
0.00%
6.83%
0.00%
11.37%
21.16%
100.00%
363,447
Sept 2021
60.64%
0.00%
6.87%
0.00%
11.49%
21.00%
100.00%
338,815
Jun 2021
60.64%
0.00%
6.89%
0.00%
11.03%
21.44%
100.00%
311,349
Mar 2021
60.67%
0.00%
6.65%
0.00%
10.89%
21.79%
100.00%
0
BIOCON promoter holding above 50% indicates strong insider confidence. Explore the Biocon P/E valuation for detailed insights.
Quarter
Promoter (%)
FII (%)
DII (%)
Govt (%)
Public (%)
Other (%)
Total (%)
Shareholders
Jan 2026
44.91%
7.14%
24.16%
0.00%
10.23%
13.55%
99.99%
394,215
Dec 2025
54.45%
7.39%
21.71%
0.00%
12.38%
4.06%
99.99%
394,279
Sept 2025
54.45%
6.61%
22.10%
0.00%
12.71%
4.12%
99.99%
413,191
Jun 2025
54.45%
6.04%
22.82%
0.00%
12.58%
4.10%
99.99%
430,217
Mar 2025
60.64%
5.66%
15.72%
0.00%
13.63%
4.34%
99.99%
424,297
Dec 2024
60.64%
5.66%
15.37%
0.00%
14.07%
4.27%
100.01%
427,705
Sept 2024
60.64%
5.93%
14.44%
0.00%
14.57%
4.42%
100.00%
439,503
Jun 2024
60.64%
5.90%
14.30%
0.00%
14.63%
4.53%
100.00%
443,513
Mar 2024
60.64%
5.63%
13.68%
0.00%
15.53%
4.52%
100.00%
470,261
Dec 2023
60.64%
6.55%
14.51%
0.00%
14.47%
3.83%
100.00%
434,339
Sept 2023
60.64%
7.96%
14.08%
0.00%
13.61%
3.70%
99.99%
415,046
Jun 2023
60.64%
0.00%
12.56%
0.00%
13.34%
13.46%
100.00%
412,441
Quarterly data helps track institutional investment cycles.
Biocon shareholding pattern reveals who owns BIOCON stock and how ownership changes over time. High promoter stakes in BIOCON often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your BIOCON trades. Biocon quarterly earnings
Combine BIOCON ownership analysis with price movements and financial performance for a complete investment picture. (See BIOCON intrinsic value calculation)